| 编号 | 细胞类型 | 细胞名称 | JCRB编号 | 动物源 | 组织来源 | 简介 |
| 1 | general cells | 1-1ras1000 | JCRB1355 | mouse | embryo, whole | The ras-transformed BALB/c 3T3 A31-1-1variant cell lines were strongly tumorinenic, but the cells were not metastatic. (Strain problem was found. Refer Important Notice at cell detail page.) |
| 2 | general cells | 1-1src | JCRB1357 | mouse | embryo, whole | The src-transformed BALB/c 3T3 A31-1-1 variant cell lines were strongly tumorinenic and metastatic.(Strain problem was found. Refer Important Notice at cell detail page.) |
| 3 | general cells | 104C1 | JCRB9036 | guinea pig | fetal body | fetal carcass, benzo(a)pyrene transformed, diploid |
| 4 | general cells | 45154 | JCRB0013 | mouse | spleen | Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. |
| 5 | general cells | 45126 | JCRB0014 | mouse | spleen | Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte. |
| 6 | general cells | 28SC-ES | JCRB1647 | human | peripheral bood | endotoxin sensitive human peripheral blood cell line (Believed to be derived from U937 cells). |
| 7 | general cells | 293 | JCRB9068 | human | kidney | transformed embryonal kidney by adenovirus (type5) |
| 8 | genetically-modified cells | 293 TRE/Cont | JCRB1533 | human | kidney | Control 293 cell line for 293 TRE/FLAG-POLK. |
| 9 | genetically-modified cells | 293_hEcad | JCRB1733 | human | kidney | 293 cell line into which human E-Cadherin gene has been transfected. |
| 10 | genetically-modified cells | 293_hSyn1 | JCRB1736 | human | kidney | 293 cell line into which human Syndecan-1 gene has been transfected. |
| 11 | genetically-modified cells | 293_hSyn4 | JCRB1735 | human | kidney | 293 cell line into which human Syndecan-4 gene has been transfected. |
| 12 | general cells | 3'-mRLh-2 | JCRB0431 | rat | liver | hepatoma, (Donryu rat) |
| 13 | general cells | 3'-mRLN-30 | JCRB0421 | rat | liver | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
| 14 | general cells | 3'-mRLN-31 | JCRB0422 | rat | liver | liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
| 15 | general cells | 39As8 | JCRB1886 | human | ascites | Peritoneal disseminated metastatic cell line established from signet ring cell gastric carcinoma (HSC-39). |
| 16 | general cells | 3LL | JCRB1348 | mouse | Lung | Lewis lung carcinoma cell line. |
| 17 | general cells | 3T3 L1 | JCRB9014 | mouse | embryo | Clonal subline of the mouse 3T3 that accumulate large amounts of triglyceride fat when the cells are in the resting state. |
| 18 | general cells | 3T3-L1 | IFO50416 | mouse | embryo | 3T3 L1 cell line is a substrain of 3T3-Swiss albino cell line. 3T3 L1 cells convert adipose-like cells at confluent. |
| 19 | general cells | 3T3-Swiss albino | JCRB9019 | mouse | embryo | fibroblast, contact inhibited, (Swiss albino mouse) |
| 20 | general cells | 3T3-Swiss albino | IFO50417 | mouse | embryo | fibroblast, contact inhibited, (Swiss albino mouse) |
| 21 | general cells | 3T6-Swiss albino | JCRB9059 | mouse | embryo | fibroblast, collagen-secreting, (Swiss albino mouse) |
| 22 | general cells | 3Y1-B Clone 1-6 | JCRB0734 | rat | embryo/fetus | fibroblast, whole embryo, (Fischer 344 rat) |
| 23 | general cells | 4-2D | JCRB0084 | mouse | NS1 x spleen cell | anti-primase complexed with DNA polymerase alpha |
| 24 | general cells | 4-8H | JCRB0083 | mouse | NS1 x spleen cell | anti-DNA polymerase alpha, IgG1 |
| 25 | general cells | 4G12 hybridoma | IFO50090 | mouse x human |
| This cell line produces human monoclonal 4G12 antibody (Ig lambda). The 4G12 antibody recognizes a glycoprotein with Mr = 65,000. Immunohistochemically, 4G12 reacts especially with lung carcinomas and with some malignant tumors. |
| 26 | general cells | 5RP7 | IFO50277 | rat | embryo | fibroblast transformed by c-Ha-ras oncogene |
| 27 | general cells | 6-23 clone 6 | IFO50270 | rat | thyroid, C cell | medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat) |
| 28 | general cells | 77N1 | IFO50280 | rat | kidney | Parental strain is NRK (normal rat kidney) cells (J. Bacteriol.,92, 1133 (1966)). |
| 29 | general cells | 7D4 | JCRB9092 | mouse x rat | hybridoma | anti-murine IL-2 receptors (rat antibody) |
| 30 | general cells | 8305C | JCRB0824 | human | thyroid | Human undifferentiated thyroid carcinoma with C:G->T:A mutation at codon 273 of p53 gene. |
| 31 | general cells | 8505C | JCRB0826 | human | thyroid | thyroid carcinoma, undifferentiated |
| 32 | general cells | 9-15c | JCRB1181 | mouse | bone marrow | Mouse C3H/He cell line. |
| 33 | general cells | A-172 | JCRB0228 | human | brain | glioblastoma |
| 34 | general cells | A-431 | JCRB0004 | human |
| epidermoid carcinoma, high expression of EGF-receptor |
| 35 | general cells | A-431 | JCRB9009 | human | epiderm | epidermoid carcinoma, high expression of EGF-receptor |
| 36 | general cells | A-431 | IFO50411 | human | epidermoid | epidermoid carcinoma, high expression of EGF receptor |
| 37 | general cells | A1 | IFO50519 | mouse | brain | derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells |
| 38 | general cells | A2058 | IFO50276 | human | melanoma | malignant melanoma, metastasis to lymph node |
| 39 | general cells | A2B5 clone 105 | IFO50284 | mouse | P3x63 Ag8 x spleen | Produces anti-chick retinal neuron glycolipid monoclonal antibody (IgM class). |
| 40 | general cells | A3/KAW | JCRB0101 | human | ascites | lymphoma, malignant |
| 41 | general cells | A31-1-1 | JCRB1356 | mouse | embryo, whole | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
| 42 | general cells | A31-714 C4 | IFO50021 | mouse | embryo, whole | fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse) |
| 43 | general cells | A4/Fuk | JCRB0097 | human | ascites | lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing |
| 44 | general cells | A549 | JCRB0076 | human | lung | Human adeno carcinoma cell line derived from lung cancer. |
| 45 | general cells | A549 | IFO50153 | human | lung | adenocarcinoma |
| 46 | general cells | A9 | JCRB0211 | mouse | skin | skin fibroblast, 8-azaguanine-resistant, (C3H mouse) |
| 47 | general cells | A9(0439)-1 | JCRB0732 | human chromosome-introduced | hybrid | contains human chromosome Xpter>Xq26::3p12>3pter (MTA with Tottori Univ. is required.) |
| 48 | general cells | A9(2621)-4 | JCRB0730 | human chromosome-introduced | hybrid | contains human chromosome 12pter>12q24::Xq22>Xqter (MTA with Tottori Univ. is required.) |
| 49 | general cells | A9(3552)-2 | JCRB0731 | human chromosome-introduced | hybrid | contains human chromosome 11pter>11q23::Xq26>Xqter (MTA with Tottori Univ. is required.) |
| 50 | general cells | A9(3884)-1 | JCRB0729 | human chromosome-introduced | hybrid | contains human chromosome 16pter>16q24::Xq26>Xqter (MTA with Tottori Univ. is required.) |
| 51 | general cells | A9(7151)-3 | JCRB0728 | human chromosome-introduced | hybrid | contains human chromosome 17pter>17q11::Xq11>Xqter (MTA with Tottori Univ. is required.) |
| 52 | general cells | A9(An4)-2 | JCRB0727 | human chromosome-introduced | hybrid | contains human chromosome # 1 (MTA with Tottori Univ. is required.) |
| 53 | general cells | A9(Bsr10) | JCRB2210 | human chromosome-introduced | skin | contains human chromosome #10 (MTA with Tottori Univ. is required.) |
| 54 | general cells | A9(BsrX) | JCRB2223 | human chromosome-introduced | skin | contains human chromosome X (MTA with Tottori Univ. is required.) |
| 55 | general cells | A9(Hygro13) | JCRB2213 | human chromosome-introduced | skin | contains human chromosome #13 (MTA with Tottori Univ. is required.) |
| 56 | general cells | A9(Hygro14) | JCRB2214 | human chromosome-introduced | skin | contains human chromosome #14 (MTA with Tottori Univ. is required.) |
| 57 | general cells | A9(Hygro21) | JCRB2221 | human chromosome-introduced | skin | contains human chromosome #21 (MTA with Tottori Univ. is required.) |
| 58 | general cells | A9(Hygro22) | JCRB2222 | human chromosome-introduced | skin | contains human chromosome #22 (MTA with Tottori Univ. is required.) |
| 59 | general cells | A9(Neo1) | JCRB2201 | human chromosome-introduced | skin | contains human chromosome # 1 (MTA with Tottori Univ. is required.) |
| 60 | general cells | A9(neo11) | JCRB2211 | human chromosome-introduced | skin | contains human chromosome #11 (MTA with Tottori Univ. is required.) |
| 61 | general cells | A9(Neo12) | JCRB2212 | human chromosome-introduced | skin | contains human chromosome #12 (MTA with Tottori Univ. is required.) |
| 62 | general cells | A9(Neo15) | JCRB2215 | human chromosome-introduced | skin | contains human chromosome #15 (MTA with Tottori Univ. is required.) |
| 63 | general cells | A9(Neo16) | JCRB2216 | human chromosome-introduced | skin | contains human chromosome #16 (MTA with Tottori Univ. is required.) |
| 64 | general cells | A9(Neo17) | JCRB2217 | human chromosome-introduced | skin | contains human chromosome #17 (MTA with Tottori Univ. is required.) |
| 65 | general cells | A9(Neo18) | JCRB2218 | human chromosome-introduced | skin | contains human chromosome #18 (MTA with Tottori Univ. is required.) |
| 66 | general cells | A9(Neo19) | JCRB2219 | human chromosome-introduced | skin | contains human chromosome #19 (MTA with Tottori Univ. is required.) |
| 67 | general cells | A9(Neo2) | JCRB2202 | human chromosome-introduced | skin | contains human chromosome # 2 (MTA with Tottori Univ. is required.) |
| 68 | general cells | A9(Neo20) | JCRB2220 | human chromosome-introduced | skin | contains human chromosome #20 (MTA with Tottori Univ. is required.) |
| 69 | general cells | A9(Neo3) | JCRB2203 | human chromosome-introduced | skin | contains human chromosome # 3 (MTA with Tottori Univ. is required.) |
| 70 | general cells | A9(Neo4) | JCRB2204 | human chromosome-introduced | skin | contains human chromosome # 4 (MTA with Tottori Univ. is required.) |
| 71 | general cells | A9(Neo5) | JCRB2205 | human chromosome-introduced | skin | contains human chromosome # 5 (MTA with Tottori Univ. is required.) |
| 72 | general cells | A9(Neo6) | JCRB2206 | human chromosome-introduced | skin | contains human chromosome # 6 (MTA with Tottori Univ. is required.) |
| 73 | general cells | A9(Neo7) | JCRB2207 | human chromosome-introduced | skin | contains human chromosome # 7 (MTA with Tottori Univ. is required.) |
| 74 | general cells | A9(Neo8) | JCRB2208 | human chromosome-introduced | skin | contains human chromosome # 8 (MTA with Tottori Univ. is required.) |
| 75 | general cells | A9(NTI8)-2 | JCRB0726 | human chromosome-introduced | hybrid | contains human chromosome # 7 (MTA with Tottori Univ. is required.) |
| 76 | general cells | ABC-1 | JCRB0815 | human | lung | adenocarcinoma |
| 77 | general cells | Ac2F | JCRB0408 | rat | liver | normal liver, diploid, (Donryu rat) |
| 78 | general cells | Ac2F(DT) | JCRB0416 | rat | liver transformed | Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat) |
| 79 | general cells | Ac2F(ST) | JCRB0417 | rat | liver transformed | Ac2F-derived, spontaneously transformed, (Donryu rat) |
| 80 | general cells | ACI-RCC | JCRB1585 | rat | kidney | Rat chemically induced renal cell carcinoma cell line. (induced by ferric nitrilotriacetate (Fe-NTA)) |
| 81 | general cells | Ad12-3Y1-Z19 | JCRB0737 | rat | embryo/fetal whole body | 3Y1 derivative, Ad12-transformed, (Fischer rat) |
| 82 | general cells | AH-7974.P3 | JCRB0714.1 | rat | ascites | Serum free rat ascited hepatoma cell line. Cells have been maintained by passage for long time. Extremely high passage number. |
| 83 | general cells | AH-7974.P3 | JCRB0714.2 | rat | ascites | Serum free rat ascited hepatoma cell line. Cells have been maintained by passage for long time. Extremely high passage number. (Date of deposit: 2015) Mycoplasma was eliminated with MC-210. |
| 84 | general cells | AH601(JTC27) | JCRB0132.1 | rat | ascites | A transplantable rat hepatoma cell line derived from ascites. |
| 85 | general cells | AH601.P3(JTC27) | JCRB0132.2 | rat | acites | AH-601 cell line adapted to a serum free medium. |
| 86 | general cells | AH601.P3(JTC27) | JCRB0132.3 | rat | acites | AH-601 cell line adupted to a serum free medium with long passage history. |
| 87 | general cells | AH66tc | JCRB0411 | rat | liver | ascites hepatoma, (Donryu rat) |
| 88 | general cells | AH70Btc | JCRB0412 | rat | liver | ascites hepatoma, (Donryu rat) |
| 89 | general cells | AIG | JCRB1105 | hamster, Chinese | lung | anchorage-independent mutant of CHL |
| 90 | general cells | AK28 | JCRB1726 | human |
| Human fibroblast cell Line with mutation of LDL receptor. |
| 91 | virus production cells | Akata | JCRB1763 | human | blood | Epstein-Barr virus (EBV)-producer cell line established from a Japanese patient with Burkitt’s lymphoma. |
| 92 | virus production cells | Akata (-) EBV-neoR | JCRB1827 | human | blood | Cell lines re-infected with recombinant EBV which genome contains neomycin resistance gene in EBV-negative Akata cells. |
| 93 | virus production cells | Akata EBER(+) | JCRB1844 | human | blood | EBV-encoded small RNA (EBER) knockout EBV knocked in both EBER 1/2 viruses were reinfected into Akata- cell line. |
| 94 | virus production cells | Akata EBER(-) EBV | JCRB1832 | human | blood | Cell lines re-infected with EBV-encoded small RNA (EBER) knockout EBV in Akata- (Akata clone from which EBV was dropped). |
| 95 | virus production cells | Akata ZKO | JCRB1869 | human | blood | EBV immediate early gene (BZLF1) knockout EBV was reinfected into Akata- cell line. |
| 96 | virus production cells | Akata Δ1 EBER2(+) | JCRB1860 | human | blood | EBV-encoded small RNA (EBER) knockout EBV knocked in EBER2 viruses were reinfected into Akata- cell line. |
| 97 | virus production cells | Akata Δ2 EBER1(+) | JCRB1851 | human | blood | EBV-encoded small RNA (EBER) knockout EBV knocked in EBER1 viruses were reinfected into Akata- cell line. |
| 98 | virus production cells | Akata Δgp85 | JCRB1871 | human | blood | EBV-encoded glycoprotein 85 (gp 85) knockout EBV was reinfected into Akata- cell line. |
| 99 | virus production cells | Akata ΔLMP2A | JCRB1861 | human | blood | EBV-encoded latent membrane protein 2A (LMP 2A) knockout EBV was reinfected into Akata- cell line. |
| 100 | general cells | Akata-EBV-N | JCRB1765 | human | blood | Epstein-Barr virus (EBV)-negative cell line established from a Japanese patient with Burkitt’s lymphoma. |
| 101 | virus production cells | Akata-EBV-P | JCRB1762 | human | blood | Epstein-Barr virus (EBV)-positive cell line established from a Japanese patient with Burkitt’s lymphoma. |
| 102 | virus production cells | Akata-eGFP-EBV | JCRB1764 | human | blood | A clone in which Akata-EBV-negative cells were reinfected with recombinant EBV in which GFP was integrated into the genome. |
| 103 | general cells | Alexander cells | IFO50069 | human | liver | hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5). |
| 104 | general cells | AM-38 | IFO50492 | human | brain | glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive |
| 105 | general cells | AP-16 | IFO50424 | mouse | brain, astrocyte-progenitor cell | Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis. |
| 106 | genetically-modified cells | AR-EcoScreen | JCRB1328 | hamster, Chinese | Ovary | AR-EcoScreen is for evaluation of a rapid in vitro androgen receptor tarnscriptional activation assay. |
| 107 | genetically-modified cells | AR-EcoScreen GR KO M1 | JCRB1761 | hamster, Chinese | ovary | AR-EcoScreen is for evaluation of a rapid in vitro androgen receptor tarnscriptional activation assay. Furthermore, this cell line specifically knocked out the glucocorticoid receptor (GR) gene. |
| 108 | general cells | ARLJ301-3 | JCRB0248 | rat | liver | liver epithelial cell, (F344/DuCrj rat) |
| 109 | general cells | AS17 | JCRB1392 | mouse x mouse |
| Hybridoma cell line producing antibody against human annexin IV. |
| 110 | general cells | ASF-4-1 | IFO50418 | human | skin fibroblast from upper arm | Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and the ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 36 years and 2 month-old |
| 111 | general cells | ASF-4-2 | IFO50419 | human | skin fibroblast from upper arm | Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 47 years and 6 month-old. |
| 112 | general cells | ASF-4-3L | JCRB1431 | human | skin | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
| 113 | general cells | ASF-4-4L1 | JCRB1441 | human | skin | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
| 114 | general cells | ASF-4-4L2 | JCRB1442 | human | skin | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
| 115 | general cells | ASF-4-5L1 | JCRB1705 | human | skin | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. |
| 116 | general cells | ASF-4-5L2 | JCRB1703 | human | skin | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. |
| 117 | general cells | ASF-4-5R1 | JCRB1709 | human | skin | Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages. |
| 118 | general cells | ASH-3 | JCRB1073 | human | cervical tissue | Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma. |
| 119 | general cells | AT/RT | JCRB1868 | human |
| atypical teratoid/rhabdoid tumor |
| 120 | general cells | AtT-20 | JCRB9098 | mouse | pituitary gland | pituitary tumor, ACTH producing, (LAF1 mouse) |
| 121 | general cells | AZ-521 | JCRB0061 | human | lymph node | Reported as Human gastric cancer cell line. The STR DNA analysis pattern of AZ-521 revealed to be identical to that of other cell line derived from human duodenum carcinoma, HuTu 80 in ATCC (registry number, HTB-40) |
| 122 | general cells | B-1 | JCRB0243 | mouse | testis | Leydig cell tumor, estrogen-dependent, (BALB/c mouse) |
| 123 | general cells | B104 | JCRB0117 | human | blood | Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells. |
| 124 | general cells | B16 melanoma | JCRB0202 | mouse | skin (melanoma) | Mouse skin melanoma cell line. |
| 125 | general cells | B2-17 | IFO50361 | human | brain | astrocytoma, thymidine kinase-deficient mutant of U-251 MG cells |
| 126 | general cells | B8/3 | JCRB0238 | mouse | bone marrow | Mouse erythroleukemia cell line. |
| 127 | general cells | B82 | JCRB0212 | mouse | skin | skin fibroblast, bromodeoxyuridine-resistant |
| 128 | virus production cells | B95-8 | JCRB9123 | cotten-top tamarin | blood | Monkey(tamarin) lymphocyte cell line producing EBV. |
| 129 | general cells | BALB-MC | JCRB0233.0 | mouse | mammary gland | mammary cancer, (BALB/cHe mouse) |
| 130 | general cells | BALB-MC.D3 | JCRB0233.1 | mouse | mammary gland | mammary cancer, (BALB/cHe mouse) |
| 131 | general cells | BALB-MC.E12 | JCRB0233.2 | mouse | mammary gland | Mouse mammary tumor cell line. |
| 132 | general cells | BALB/3T3 A31-1-1 | JCRB0601 | mouse | embryo | fibroblast, contact inhibited, (Strain problem was found. Refer Important Notice at cell detail page.) |
| 133 | general cells | BALB/3T3 clone A31 | JCRB9005 | mouse | embryo | fibroblast, contact inhibited, (BALB/c mouse) |
| 134 | general cells | Balb/3T3-A31-1-1 | IFO50070 | mouse | embryo, whole | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
| 135 | general cells | Balb/c 3T3 A31-1-13 | IFO50299 | mouse | embryo, whole | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
| 136 | general cells | Balb/c 3T3 A31-I-1 | IFO50298 | mouse | embryo, whole | fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
| 137 | general cells | BALL-1 | JCRB0071 | human | peripheral blood | Acute lymphoblastoid leukemia (ALL) cell line from human. |
| 138 | general cells | BALM-13 | JCRB1791 | human | peripheral blood | B cell leukemia cell line |
| 139 | general cells | BALM-14 | JCRB1804 | human | peripheral blood | B cell leukemia cell line |
| 140 | general cells | BALM-16 | JCRB1795 | human | peripheral blood | B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;22)(q24;q11), hypercalcemia, mRNA expression of PTHrP |
| 141 | general cells | BALM-18 | JCRB1796 | human | peripheral blood | B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;14)(q24;q32) |
| 142 | general cells | BALM-19 | JCRB1798 | human | bone marrow | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia, mRNA expression of PTHrP |
| 143 | general cells | BALM-20 | JCRB1797 | human | bone marrow | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
| 144 | general cells | BALM-21 | JCRB1817 | human | bone marrow | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
| 145 | general cells | BALM-22 | JCRB1813 | human | bone marrow | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
| 146 | general cells | BALM-23 | JCRB1800 | human | bone marrow | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
| 147 | general cells | BALM-24 | JCRB1843 | human | peripheral blood | B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32) |
| 148 | general cells | BALM-25 | JCRB1801 | human | bone marrow | B cell leukemia cell line, ALL-L3 cell line |
| 149 | general cells | BALM-26 | JCRB1803 | human | bone marrow | B cell leukemia cell line, ALL-L2 cell line, hypercalcemia |
| 150 | general cells | BALM-27 | JCRB1821 | human | bone marrow | B cell leukemia cell line, ALL-L3 cell line |
| 151 | general cells | BALM-6 | JCRB1783 | human | bone marrow | B cell leukemia cell line |
| 152 | general cells | BALM-7 | JCRB1782 | human | bone marrow | B cell leukemia cell line |
| 153 | general cells | BALM-8 | JCRB1784 | human | bone marrow | B cell leukemia cell line |
| 154 | general cells | BALM-9 | JCRB1785 | human | peripheral blood | B cell leukemia cell line |
| 155 | general cells | BALM-9K | JCRB1787 | human | peripheral blood | B cell leukemia cell line |
| 156 | general cells | BALM-9KL | JCRB1788 | human | peripheral blood | B cell leukemia cell line |
| 157 | general cells | BALM-9L | JCRB1794 | human | peripheral blood | B cell leukemia cell line |
| 158 | general cells | BALM-9N | JCRB1790 | human | peripheral blood | B cell leukemia cell line |
| 159 | general cells | BCE C/D-1b | JCRB9129 | bovine | cornea | Bovine corneal endothelial cell line. |
| 160 | general cells | BCL1 Clone CW13.20 | JCRB9117 | mouse | peripheral blood | Mouse B cell line, where the differentiation is stimulated by B cell differentiation factors. |
| 161 | general cells | Becker | IFO50289 | human | brain | astrocytoma, GFAP-negative |
| 162 | general cells | BeWo | JCRB9111 | human | fetal placenta | Human placenta derived cell line. |
| 163 | general cells | Bhas 42 | JCRB0149 | mouse | whole body of embryo | BALB 3T3 A31-1-1 cell line transfected with H-ras gene. The cell line keeps characteristics of the contact inhibition and the transfomation is induced by phorbol ester alone. No initialization required. (Strain problem was found. Refer Important Notice at cell detail page.) |
| 164 | general cells | BHK-21(C-13) | JCRB9020 | hamster, Syrian | kidney | kidney, subclone of BHK-21 |
| 165 | general cells | BLACK-93A | JCRB1780 | human | Pleural effusion | Burkitt lymphoma cell line. |
| 166 | general cells | BOKU | IFO50323 | human | uterine cervix | cervical squamous cell carcinoma |
| 167 | general cells | BRL-3A | JCRB0025 | rat | liver | MSA (somatomedin-like) protein producing, (Buffalo rat) |
| 168 | general cells | BRL-3A | JCRB9114 | rat | liver | MSA (somatomedin-like) protein producing, (Buffalo rat) |
| 169 | general cells | BS-C-1 | JCRB9126 | monkey, African green | kidney | Kidney cell line of the african green monkey. |
| 170 | general cells | BS-C-1 | IFO50413 | monkey, African green | kidney | suitable host for transfection experiments of SV40 vectors |
| 171 | general cells | BT-A | JCRB1927 | bovine | blastcyst | bovine trophoblastic cell line |
| 172 | general cells | BT-C | JCRB1866 | bovine | blastcyst | bovine trophoblastic cell line |
| 173 | general cells | BW5147.G.1.4.OUA-R.1 | JCRB9002 | mouse |
| lymphoma, T cell lymphoma, (AKR/J mouse) |
| 174 | general cells | c-WRT-7-LR | JCRB0168 | rat |
| A transplantable rat myelomonocytic leukemia cell line induced in a WKA rat by neonatal injections of RLV (Rauscher leukemia virus). |
| 175 | general cells | C32TG | JCRB0227 | human | skin | Human 6TG resistant amelanotic melanoma cell line from skin. |
| 176 | general cells | C3H/10T1/2 clone 8 | JCRB9080 | mouse | embryo | fibroblast, contact inhibited, (C3H mouse) |
| 177 | general cells | C3H/10T1/2-clone 8 | JCRB0003 | mouse | embryo | fibroblast, contact inhibited, (C3H mouse) |
| 178 | general cells | C3H/10T1/2-clone8 | IFO50415 | mouse | embryo | This cell line is useful for transformation studies. |
| 179 | general cells | C3H/MCA clone 15 | IFO50042 | mouse | embryo | Parent strain is C3H/10T/1/2 clone 8. |
| 180 | general cells | C6 | JCRB9096 | rat | brain | glial tumor, GFAP-positive |
| 181 | general cells | C6 | IFO50110 | rat | brain | glial tumor, GFAP-positive |
| 182 | general cells | C6-SF2 | IFO50425 | rat | brain | C6 subline adapted to serum-free medium |
| 183 | general cells | C6/36 | IFO50010 | mosquito | hatched larvae | This cell line is useful for replication of flavoviruses and dengue virus. |
| 184 | general cells | Ca Ski | IFO50007 | human | uterine cervix | Human epidermoid cervical cancer cell line. |
| 185 | general cells | Ca9-22 | JCRB0625 | human | gingival | squamous carcinoma, gingiva |
| 186 | general cells | Caki-1 | JCRB0801 | human | renal | renal clear cell carcinoma |
| 187 | general cells | CaR-1 | JCRB0207 | human | rectum | adenocarcinoma |
| 188 | general cells | CAS-9 | JCRB1385 | mouse x rat |
| Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin. |
| 189 | general cells | CCD 841 CoN | IFO50482 | human | colon | Stop providing (For finite cell growth). This cell line is keratin-negative, therefore difinitive evidence for epithelial origin is lacking. The lots preserved in the cell bank hardly proliferate. |
| 190 | general cells | CCD-14Br | JCRB9101 | human | bronchiole | bronchus, diploid |
| 191 | general cells | CCD-33Co | IFO50483 | human | colon | Human fibroblast cell line established from normal colon. The ampoules preserved in the cell bank hardly proliferate. |
| 192 | general cells | CCK-81 | JCRB0208 | human | colon | adenocarcinoma |
| 193 | general cells | CCRF S-180 II | JCRB9089 | mouse | sarcoma | S-180 sarcoma derivative |
| 194 | general cells | CCRF-CEM | JCRB0033 | human | peripheral blood (buffy coat) | leukemia, acute T lymphoblastic |
| 195 | general cells | CCRF-CEM | JCRB9023 | human | peripheral blood buffy coat | Human cell line established from patient with acute lymphoblastic leukemia. |
| 196 | general cells | CCRF-CEM | IFO50412 | human | peripheral blood | leukemia, acute T lymphoblastic |
| 197 | general cells | CCRF-HSB2 | JCRB0031 | human | peripheral blood (buffy coat) | Human T-lymphoblastic leukemia cell line from implanted tumor in Syrian hamster. |
| 198 | general cells | CCRF-SB | JCRB0032 | human | peripheral blood (buffy coat) | leukemia, acute B lymphoblastic |
| 199 | general cells | CCRF-SB | IFO50026 | human | peripheral blood | Karyotypes appeared normal diploid. This cell line does not synthesize immunogloblins. |
| 200 | general cells | Ch 1 Es | JCRB9037 | goat | esophagus | Fibroblastic cell line from normal fetal goat esophagus. |
